Biosion Completes Series B Financing Round Led by Guangfa Xinde Investment
Biosion, a global, clinical-stage biotech committed to developing antibody-based therapies targeting immune and oncologic diseases,...
Finance
Shenzhen Würzburg Dynamics Raises RMB 100 Million in Series A Financing Round
China-based Shenzhen Würzburg Dynamics has reportedly raised RMB 100 million (USD 14.36 million) in a...
AcornMed Raises RMB 200 Million in Series B Financing Led by Yikai Venture Capital
AcornMed, a tumor precision medicine specialist based in Beijing, has reportedly raised RMB 200 million...
Jiangsu Vcare PharmaTech Raises RMB 200 Million in Series B Financing Round
China-based Jiangsu Vcare PharmaTech Co. Ltd has reportedly raised over RMB 200 million (USD 28.67...
Nanjing Pharmaceutical to Acquire Majority Stakes in Three Jiangsu Subsidiaries
China-based Shanghai-listed Nanjing Pharmaceutical Co., Ltd (SHA: 600713) is set to acquire a respective 55%,...
MSD and Kelun Biotech Ink Record-Breaking ADC Deal
Merck, Sharp & Dohme (MSD, NYSE: MRK) has set a new benchmark for the largest...
Biomica Raises Funds for Tumor Immunity and IBD Drug Development
Israel-based start-up Biomica has reportedly raised an undisclosed amount of money via another financing round,...
Redpine Medical Raises ‘Hundreds of Millions’ in Series C Financing Round
Redpine Medical, a single-use endoscope maker based in Guangzhou, has reportedly raised “hundreds of millions”...
Sibionics Raises RMB 500 Million in Series D Financing Round
Shenzhen-based chronic disease device maker Sibionics has reportedly raised close to RMB 500 million (USD...
Waker Bioscience Raises Angel Funding for ISA Technology Upgrades
Waker Bioscience, an integration site analysis (ISA) specialist based in Shanghai, has reportedly raised “tens...
Ronovo Surgical Raises Pre-Series B Funding for Surgical Robot Development
Ronovo Surgical, a minimally invasive surgery device maker based in Shanghai, has reportedly raised “tens...
TowardPi Raises RMB 300 Million in Series C Financing Round
China-based ophthalmology device maker TowardPi (Beijing) Medical Technology Ltd has reportedly raised close to RMB...
Endo International Licenses TLC’s Phase III Nanomedicine for OA Knee Pain
Ireland-based Endo International plc (NASDAQ: ENDP) has announced a licensing deal between its subsidiary Endo...
Meihua Medtech Secures Over RMB 100M in Series B Financing Led by Eight Roads and Sunland
China’s Zhuhai Meihua Medical Technology Co., Ltd, a leading clinical microbiology laboratory overall solutions provider,...
InnerMedical Secures RMB 300M in Series D Funding Led by Green Pine and Simiao
InnerMedical Co., Ltd, a leading chronic disease diagnosis and treatment solutions provider based in Shenzhen,...
Everest Medicines Achieves Preclinical Milestone for mRNA Rabies Vaccine
China-based Everest Medicines (HKG: 1952) has announced that the company has achieved the preclinical proof-of-concept...
Alternative Bio Completes $15M Seed Round to Advance Cancer Therapeutics
Singapore-based Alternative Bio Inc. has announced the completion of a seed financing round at USD...
4B Technologies Raises RMB 100M in Pre-Series B Financing Round
China-based 4B Technologies Investments Ltd, a biotech focused on central nervous system (CNS) drug development,...
Harbour BioMed’s Nona Biosciences Licenses Antibody Platform to Kelun-Biotech
Harbour BioMed (HKG: 2142), a biotech operating out of the Netherlands, the United States, and...
ExoNeuglia Secures Angel Funding for iPSC-Based Cell Therapy
ExoNeuglia, a stem-cell-focused biotech based in Suzhou, reportedly raised “tens of millions” of renminbi in...